Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19)
Not Applicable
Not yet recruiting
- Conditions
- novel coronavirus pneumonia (COVID-19)
- Registration Number
- ITMCTR2000002960
- Lead Sponsor
- The First Affiliated Hospital of He'nan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients with pneumonia infected by new coronavirus;
2. To sign informed consent.
Exclusion Criteria
Serious cognitive or mental disorder.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the key TCM syndrome patterns identified in ITMCTR2000002960 for different stages of COVID-19 progression?
How do TCM syndrome classifications in ITMCTR2000002960 correlate with molecular biomarkers for SARS-CoV-2 pathogenesis?
What evidence supports the use of TCM interventions in ITMCTR2000002960 for cytokine storm mitigation in severe COVID-19?
Are there specific TCM syndrome subtypes in ITMCTR2000002960 that predict differential responses to antiviral therapies?
How does the observational design of ITMCTR2000002960 contribute to understanding TCM's role in managing post-acute sequelae of SARS-CoV-2 infection (PASC)?